Jan 09, 2023 / 09:30PM GMT
Jessica Macomber Fye - JPMorgan Chase & Co, Research Division - Analyst
Great. Good afternoon, everyone. My name is Jess Fye. I'm the large cap biotech analyst at JPMorgan, and we are delighted to be continuing the conference today with United Therapeutics. We are not switching rooms for Q&A. We're going to stay right here. There's a couple of ways you can ask questions. You can raise your hand and someone will bring you a mic. You can enter it electronically on a portal and send it to me on an iPad, and I can ask the management team or you can just listen to me ask questions. But hopefully, you have some of your own.
Well, anyway, with that, let me pass it over to United Therapeutics Chairperson and CEO, Martine Rothblatt, for the presentation.
Martine A. Rothblatt - United Therapeutics Corporation - Founder, Chairman & CEO
Thank you, Jess. Thank you, everybody. I'd like to start our presentation by just saying a comment about the company's tagline, enabling inspiration. As a CEO, when I think about what my fundamental job is at United
United Therapeutics Corp at JPMorgan Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot